April 27, 2021

[FEATURED] High-Risk Class D IVDs: Some Good News, Some Bad News About IVDR Implementation

The European Commission’s just updated Rolling Implementation Plan for the MDR and IVDR shows delays in key structures for high-risk IVDs. Recent guidance clarifies how and when these products can still proceed to CE marking.

Do you like it?0
April 20, 2021

[FEATURED] Medtech Standards Request Advances – But Too Late For MDR/IVDR First Wave

The medtech sector may, at last, be one step closer to ensuring standards are drafted or revised under the EU’s MDR and IVDR. But delays have already meant industry has had to adopt “Plan B.”

Do you like it?0
November 17, 2020

[FEATURED] IVDR Implementation Not Yet On Track: What The Diagnostics Sector Needs To Do

The start date for voluntary registration in the Eudamed 3 database is fast approaching. It is open to all medtech manufacturers with CE marked medical devices from 1 December.

Do you like it?0
November 2, 2020

[FEATURED] EU Faces MDR Failure Unless It Adjusts To COVID-19 Crisis And Grows Notified Bodies

Is the current pandemic too big a hurdle for the EU’s medtech regulators and industry alike? What else might hold EU medtech back from the successful implementation of the MDR?

Do you like it?0
June 10, 2020

[FEATURED] Why The EU Urgently Needs A One-Year Delay For The IVDR And EU-Wide Exceptions For IVDs

The medtech industry’s call for a one-year delay to the Medical Device Regulation and for EU-wide exceptions from usual medical device rules was granted recently. But not for IVDs, where the situation is described as “grim.”

Do you like it?0

Named the #1 Regulatory Services Company 2022 by Life Sciences Review

X